(Q54937014)

English

OVCAR-8

cell line

OVCAR 8
NIH:OVCAR-8
OVCAR8
OVCAR.8
OVCA8

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

1 reference

Cellosaurus release 49

14 July 2024

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers

1 reference

Cellosaurus release 49

14 July 2024

Gene expression patterns in ovarian carcinomas

1 reference

Cellosaurus release 49

14 July 2024

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

Cellosaurus release 49

14 July 2024

DNA fingerprinting of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

Therapeutic reactivation of mutant p53 protein by quinazoline derivatives

1 reference

Cellosaurus release 49

14 July 2024

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs

1 reference

Cellosaurus release 49

14 July 2024

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

Cellosaurus release 49

14 July 2024

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 49

14 July 2024

Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

1 reference

Cellosaurus release 49

14 July 2024

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

Cellosaurus release 49

14 July 2024

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

1 reference

Cellosaurus release 49

14 July 2024

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

1 reference

Cellosaurus release 49

14 July 2024

Evaluating cell lines as tumour models by comparison of genomic profiles

1 reference

Cellosaurus release 49

14 July 2024

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

Cellosaurus release 49

14 July 2024

Global proteome analysis of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

Type-specific cell line models for type-specific ovarian cancer research

1 reference

Cellosaurus release 49

14 July 2024

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

Cellosaurus release 49

14 July 2024

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

Cellosaurus release 49

14 July 2024

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

1 reference

Cellosaurus release 49

14 July 2024

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

1 reference

Cellosaurus release 49

14 July 2024

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

Cellosaurus release 49

14 July 2024

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 49

14 July 2024

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

Cellosaurus release 49

14 July 2024

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 49

14 July 2024

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

Cellosaurus release 49

14 July 2024

HLA class I and II genotype of the NCI-60 cell lines

1 reference

Cellosaurus release 49

14 July 2024

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 49

14 July 2024

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

Cellosaurus release 49

14 July 2024

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer

1 reference

Cellosaurus release 49

14 July 2024

Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 49

14 July 2024

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

Cellosaurus release 49

14 July 2024

Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer

1 reference

Cellosaurus release 49

14 July 2024

STR Profiling of Human Cell Lines: Challenges and Possible Solutions to the Growing Problem

1 reference

Cellosaurus release 49

14 July 2024

Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities

1 reference

Cellosaurus release 49

14 July 2024

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

Cellosaurus release 49

14 July 2024

Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location

1 reference

Cellosaurus release 49

14 July 2024

A resource for cell line authentication, annotation and quality control

1 reference

Cellosaurus release 49

14 July 2024

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression

1 reference

Cellosaurus release 49

14 July 2024

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

high grade ovarian serous adenocarcinoma

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/BTO_0003054

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/EFO_0005444

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54937014&oldid=2258524784"